GOV.UK gov.uk 2026-07-03 14:25

Semaglutide (Wegovy) approved to treat form of liver disease

The semaglutide injection has been approved to treat metabolic-associated steatohepatitis (MASH) in adults with moderate-to-advanced liver fibrosis.

Read full article at GOV.UK ↗

This summary is provided by Daily Junction. The original article is published by GOV.UK and all rights remain with the original publisher.

Related coverage on Daily Junction

Daily Briefing

The day's biggest stories in one free email. Join 12,664 readers.